Johnson & Johnson’s Nipocalimab Receives FDA Fast Track Designation for FNAIT Treatment
SPRING HOUSE, PA — In a significant advancement for maternal and fetal health, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has awarded Fast Track designation …
Johnson & Johnson’s Nipocalimab Receives FDA Fast Track Designation for FNAIT Treatment Read More